Ayalon Insurance Company’s iShares Biotechnology ETF IBB Stock Holding History

Ayalon Insurance Company’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$206K	Hold	2,325	–	–	0.17%	39
2016 Q3	$224K	Hold	2,325	–	–	0.19%	37
2016 Q2	$203K	Hold	2,325	–	–	0.17%	43
2016 Q1	$208K	Hold	2,325	–	–	0.17%	51
2015 Q4	$262K	Hold	2,325	–	–	0.22%	56
2015 Q3	$245K	Hold	2,325	–	–	0.2%	60
2015 Q2	$287K	Hold	2,325	–	–	0.21%	59
2015 Q1	$266K	Buy	+2,325	New	+$256K	0.16%	73

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ayalon Insurance Company's IBB Position: Q4 2016 in Review

Ayalon Insurance Company held its iShares Biotechnology ETF (IBB) position steady in Q4 2016 at 2,325 shares worth $206K. The position accounts for 0.17% of the portfolio, ranked #39.

Ayalon Insurance Company first reported a position in IBB in Q1 2015 and has held it in 8 quarters since. The position peaked at $287K in Q2 2015. 522 funds tracked by Wall St. Rank hold IBB as of Q4 2016.

Ayalon Insurance Company held 2,325 shares of iShares Biotechnology ETF worth $206K as of Q4 2016.
Ayalon Insurance Company left its iShares Biotechnology ETF share count unchanged in Q4 2016.
iShares Biotechnology ETF made up 0.17% of Ayalon Insurance Company's portfolio in Q4 2016, its #39 holding.
Ayalon Insurance Company first reported a position in iShares Biotechnology ETF in Q1 2015 and has held it in 8 quarters since.
Ayalon Insurance Company's iShares Biotechnology ETF position peaked at $287K in Q2 2015.
522 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2016.

Based on Ayalon Insurance Company's 13F filing for Q4 2016, filed 13 Feb 2017.